Results 241 to 250 of about 363,823 (338)

Dapagliflozin alleviates high‐fat‐induced obesity cardiomyopathy by inhibiting ferroptosis

ESC Heart Failure, Volume 12, Issue 2, Page 1358-1373, April 2025.
Abstract Aim: Dapagliflozin (Dapa) is a novel hypoglycaemic agent with multiple cardiovascular protective effects, and it is widely used in treatment of heart failure patients, but whether it can improve obese phenotype of heart failure and its mechanism is still unclear.
Di Chen, Jiahao Shi, Yue Wu, Lizhu Miao, Zilin Wang, Yixuan Wang, Siwei Xu, Yu Lou   +7 more
wiley   +1 more source

Efficacy and safety of acupuncture for arrythmias: an overview of systematic reviews and Meta-analyses. [PDF]

J Tradit Chin Med
Ci W, Yawen C, Jiaying W, Jixin C, Xue MA, Xianliang W, Jingyuan M.   +6 more
europepmc   +1 more source

Clinical relevance of heart arrhythmias [PDF]

, 2019
van Loon, Gunther
core  

Correction: “Re-evaluation of variants of uncertain significance in patients with hereditary arrhythmogenic disorders”

BMC Cardiovascular Disorders
Sarah Martin, Tina Jenewein, Christof Geisen, Stefanie Scheiper-Welling, Silke Kauferstein   +4 more
doaj   +1 more source

Early Ventricular Arrhythmias Correlate with Adverse Outcome in Takotsubo Syndrome: Analysis of a Large Single-Center Database. [PDF]

J Cardiovasc Dev Dis
Güler-Eren S, Güner F, Wanjek CT, Könemann H, Alhourani N, Kreimer F, Wolfes J, Rath B, Ellermann C, Köbe J, Reinke F, Frommeyer G, Wegner F, Eckardt L.   +13 more
europepmc   +1 more source

Data Analysis of Heart Rate Variability and Arrhythmia in Patients with Paroxysmal Atrial Fibrillation [PDF]

Huayong Jin, Lijiang Ding, Binglei Li, Jianming Zhang   +3 more
openalex   +1 more source

Mortality risk stratification for Takotsubo syndrome: Evaluating CRP measurement alongside the InterTAK prognostic score

ESC Heart Failure, Volume 12, Issue 2, Page 1427-1436, April 2025.
Abstract Background and objectives Initially described as a benign acute cardiomyopathy, Takotsubo syndrome has been linked to elevated mortality rates. Emerging evidence suggests that unresolved myocardial inflammation may contribute to this adverse prognosis.
Loïc Faucher, Kensuke Matsushita, Shinnosuke Kikuchi, Taraneh Tatarcheh, Benjamin Marchandot, Amandine Granier, Said Amissi, Antonin Trimaille, Laurence Jesel, Patrick Ohlmann, Kiyoshi Hibi, Valérie Schini‐Kerth, Olivier Morel   +12 more
wiley   +1 more source

Breaking the Rhythm: Extracorporeal Membrane Oxygenation (ECMO) as a Life Saver in a Case of Resistant Arrhythmia and Cardiac Arrest. [PDF]

Cureus
Fadl AB, Fadl A, Nadeem R.
europepmc   +1 more source

Prevalence of undiagnosed common mental disorders and its association with quality of life among patients attending the arrhythmia clinic of a large tertiary care hospital in Southern India

, 2017
Gopal Chandra Ghosh, DonaeElizabeth George, Anandaroop Lahiri, Prasanna Samuel, David Chase, JohnRoshan Jacob   +5 more
openalex   +1 more source

Cardiovascular toxicity induced by TKIs in patients with chronic myeloid leukaemia: Are women and men different?

ESC Heart Failure, Volume 12, Issue 2, Page 1447-1454, April 2025.
This study analyzes 148 patients (66 women and 82 men) with chronic myeloid leukemia treated with tyrosine kinase inhibitors, focusing on cardiovascular adverse events. The risk assessment, performed using the HFA/ICOS score, reveals sex‐specific differences: venous thrombosis is more common in women, while arterial thrombosis predominates in men.
Cristina Madaudo, Daniela Di Lisi, Antonio Cannatà, Federica Manfrè, Celeste Vullo, Marco Santoro, Ciro Botta, Salvatrice Mancuso, Sergio Siragusa, Alfredo Ruggero Galassi, Giuseppina Novo   +10 more
wiley   +1 more source